MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever

Abstract Objectives Differential diagnosis in children with prolonged fever is challenging. In particular, differentiating systemic-onset JIA (SJIA) from infectious diseases is difficult. Biomarkers are needed that support the diagnostic work-up. The aim of this study was to validate the usefulness...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rheumatology (Oxford, England) England), 2022-07, Vol.61 (7), p.3082-3092
Hauptverfasser: Park, Carolin, Miranda-Garcia, María, Berendes, Rainer, Horneff, Gerd, Kuemmerle-Deschner, Jasmin, Ganser, Gerd, Huppertz, Hans-Iko, Minden, Kirsten, Haas, Johannes-Peter, Jansson, Annette F, Borte, Michael, Schuetz, Catharina, Oommen, Prasad, Frosch, Michael, Schlueter, Bernhard, Richter-Unruh, Annette, Kessel, Christoph, Hinze, Claas, Wittkowski, Helmut, Roth, Johannes, Foell, Dirk, Holzinger, Dirk
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Objectives Differential diagnosis in children with prolonged fever is challenging. In particular, differentiating systemic-onset JIA (SJIA) from infectious diseases is difficult. Biomarkers are needed that support the diagnostic work-up. The aim of this study was to validate the usefulness of Myeloid-related protein 8/14 (MRP8/14) measurements in the diagnostic work-up of febrile children and to transfer it to clinical practice. Methods Data for 1110 paediatric patients were included and divided into two cohorts: (cohort A) for validation of MRP8/14 test performance with three different testing systems: the experimental ELISA, commercial ELISA and an innovative (point-of-care test) lateral flow immunoassay (LFIA); (cohort B) to validate the diagnostic accuracy with the two latter assays. Results In cohort A (n = 940), MRP8/14 was elevated in SJIA (12 110 ± 2650 ng/ml mean ± 95% CI) compared with other diagnoses (including infections and autoinflammatory diseases; 2980 ± 510 ng/ml) irrespective of fever and anti-inflammatory treatment (P 
ISSN:1462-0324
1462-0332
DOI:10.1093/rheumatology/keab729